Access cutting-edge breast cancer treatment through this clinical trial at a research site in Bethesda. Study-provided care at no cost to qualified participants.
Access breast cancer specialists in Bethesda at no cost
This study follows strict safety protocols and ethical guidelines
All study-related breast cancer treatment provided free
This is a Phase 3, open-label, randomized, clinical trial evaluating the efficacy and safety of gedatolisib plus fulvestrant and CDK4/6 Inhibitors for the treatment of patients with locally advanced or metastatic HR+/HER2- advanced breast cancer.
Sponsor: Celcuity Inc
Check if you qualify for this breast cancer clinical trial in Bethesda, MD
If you're searching for breast cancer treatment options in Bethesda, MD, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Bethesda research site is actively enrolling participants for this clinical trial. You'll receive care from experienced breast cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.